English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Lipids play an important role as risk or protective factors in Alzheimer's disease (AD). Previously it has been shown that plasmalogens, the major brain phospholipids, are altered in AD. However, it remained unclear whether plasmalogens themselves are able to modulate amyloid precursor protein (APP) processing or if the reduced plasmalogen level is a consequence of AD. Here we identify the plasmalogens which are altered in human AD  postmortem  brains and investigate their impact on APP processing resulting in A β  production. All tested plasmalogen species showed a reduction in  γ -secretase activity whereas  β - and  α -secretase activity mainly remained unchanged. Plasmalogens directly affected  γ -secretase activity, protein and RNA level of the secretases were unaffected, pointing towards a direct influence of plasmalogens on  γ -secretase activity. Plasmalogens were also able to decrease  γ -secretase activity in human  postmortem  AD brains emphasizing the impact of plasmalogens in AD. In summary our findings show that decreased plasmalogen levels are not only a consequence of AD but that plasmalogens also decrease APP processing by directly affecting  γ -secretase activity, resulting in a vicious cycle: A β  reduces plasmalogen levels and reduced plasmalogen levels directly increase  γ -secretase activity leading to an even stronger production of A β  peptides.

Plasmalogens Inhibit APP Processing by Directly Affectingγ-Secretase Activity in Alzheimer’s Disease